cytiva cell & gene therapy

Takeda walks away from cell therapy in priority U-turn

Japanese pharma Takeda has pulled the plug on its cell therapy efforts, despite its strong prior focus on the modality.…

FDA accepts Mesoblast’s latest BLA for paediatric GvHD cell therapy 

Mesoblast has announced that the US Food and Drug Administration (FDA) has accepted a resubmitted biologics license application (BLA) for…